Overview


According to FutureWise analysis, the market for Anorexiants is estimated to be US$ 1.06 billion in 2023 and is expected to reach US$ 1.62 billion by 2031 at a CAGR of 5.50% over the forecast period of 2023-2031.

Anorexiants are drugs used to suppress hunger and are also known as appetite suppressors. These classes of drugs are used to aid in reducing appetite and food intake. They work on the central nervous system (CNS) to influence the neurotransmitters and hormones to control and regulate the hunger and satiety of an individual. Anorexiants primarily work by affecting neurotransmitters in the brain. They target chemicals such as norepinephrine, serotonin, and dopamine, which affect appetite regulation, mood, and energy expenditure.

Anorexiants are prescribed for individuals with 30 or higher BMI (Body mass index), which are considered obese. They may also be named for those with a BMI of 27 or higher if they have comorbidities like hypertension, diabetes, or high cholesterol. There are various types of anorexiants, some of which are Phentermine, which is the most commonly prescribed anorexiant medication, and it works by stimulating the release of norepinephrine that suppresses the appetite; Diethylpropion, which is similar to phentermine, also stimulates the release of norepinephrine but also inhibits the serotonin reuptake. Topiramate/Phentermine Combination that affects both appetite regulation and satiety. Anorexiants are available in various forms, including immediate-release tablets and extended-release capsules. The choice of form depends on the specific medication and the patient's needs. Anorexiants are not standalone solutions for weight loss. They are meant to be part of a comprehensive weight loss plan with a low-calorie diet, regular exercise, and behavioural modifications.

FutureWise Market Research has published a report that provides an insightful analysis of Anorexiants Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts’ projects that Anorexiants Market will experience a significant growth.

According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Akrimax Pharmaceuticals, LLC
  • Teva Pharmaceuticals
  • Janssen Ortho, LLC
  • Roche Pharmaceuticals
  • Arena Pharmaceuticals GmbH
  • Novo Nordisk A/S
  • Abbott Pharmaceuticals PR Ltd.
  • Epic Pharma, LLC
  • Patheon Pharmaceuticals Inc
  • Catalent Pharma Solutions, LLC
  • Recordati Rare Diseases Inc.
  • MOVA Pharmaceuticals

(Note: The list of the major players will be updated with the latest market scenario and trends)

Today, youngsters are indulging in various ill food habits such as high consumption of junk food, and due to the lack of time, they are relying on readily available packaged food and junk food, which is the leading cause of obesity and hence is a driving market for the anorexiants market. Overindulgence in addictions like alcohol consumption and cigarette smoking is not only affecting their organs internally, but it is also a cause of obesity, again a factor of progress in the market growth. The rising incidence of the obesity epidemic is a significant driver. With this rise in number, there is a considerable demand for weight solutions, including anorexiants. Growing awareness among individuals about their health and risk associated with obesity, such as the causes of multiple diseases, and seeking medical interventions, including anorexiants, under the guidance of proper and trained healthcare professionals are shifting the market growth positively. Ongoing research and development on the drugs and methods for obesity are leading to effective and improved anorexiant formulations. These advancements can increase the acceptance and adoption of anorexiants. Healthcare providers and public and private organizations are adopting a holistic approach to weight management programs combined with using anorexiants and dietary habits, bolstering the market's revenue growth.

However, anorexiants can have potential side effects, and overuse or misuse of these drugs can be poisonous and may not be suitable for the individual's health. This can lead to certain medical conditions, such as cardiovascular disorders, restraining the market—the availability of alternative weight loss methods such as diet plans. Workouts, healthy drinks, bariatric surgery, and nonprescription supplements can impact the market growth in a negative sense and are responsible for constraining the market growth.

By Drug Class

  • Catecholamines Anorexiants
  • Serotonin Anorexiants

By Route of Administration

  • Oral
  • Subcutaneous

By End User

  • Institutional sales
  • Hospitals
  • Clinics
  • Retail sales
  • Online pharmacies
  • Mail Order Pharmacies

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process. 

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America holds the largest market share due to the rise in the prevalence of obesity due to the sedentary lifestyle, the development and approach towards adopting new drugs, well-established health infrastructure, early technological advancements, and high healthcare expenditure. Asia-Pacific is a rapidly growing market due to the prevalence of increasing public awareness about anorexiant drugs and rising demand for new, improved treatment options. Further, growing cases of weight gain and consequent obesity, expanded access to healthcare services, and improvised healthcare infrastructure are propelling the market growth in this region. In addition, government initiatives are playing a significant role in raising funds and promoting advanced healthcare technologies.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the of Anorexiants Market By Drug Class, By Route of Administration, By End User and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represents in format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. 
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

 

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Anorexiants Market Variables, Trends and Scope
    •   1. Market LineProducts Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Anorexiants Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Anorexiants Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Anorexiants Market, By Drug Class Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Catecholamines Anorexiants
        2. Serotonin Anorexiants

  • 8.   Global Anorexiants Market, By Route of Administration Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Oral
        2. Subcutaneous

  • 9.   Global Anorexiants Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Institutional sales
        2. Hospitals
        3. Clinics
        4. Retail sales
        5. Online pharmacies
        6. Mail Order Pharmacies

  • 10.   North America Anorexiants Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Anorexiants Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Anorexiants Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Anorexiants Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Anorexiants Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Akrimax Pharmaceuticals, LLC
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Teva Pharmaceuticals
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Janssen Ortho, LLC
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Roche Pharmaceuticals
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Arena Pharmaceuticals GmbH
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Novo Nordisk A/S
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Abbott Pharmaceuticals PR Ltd.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Epic Pharma, LLC
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Patheon Pharmaceuticals Inc
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Catalent Pharma Solutions, LLC
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Recordati Rare Diseases Inc
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. MOVA Pharmaceuticals
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients